Skip to content

Clinical trials

Phase 2 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Clear all

217 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20019
20028
20037
200412
200510
200611
20079
20085
20092
20105
20118
20127
20135
20145
20158
20164
20179
20188
20197
20206
202111
20227
20237
20246
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed127
Terminated34
Recruiting26
Active, not recruiting14
Not yet recruiting6
Unknown status5
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center23
City of Hope Medical Center12
Memorial Sloan Kettering Cancer Center12
Case Comprehensive Cancer Center10
Incyte Corporation10
National Cancer Institute (NCI)10
H. Lee Moffitt Cancer Center and Research Institute7
M.D. Anderson Cancer Center7
Masonic Cancer Center, University of Minnesota6
Roswell Park Cancer Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders217
Myelodysplastic Syndromes133
Leukemia, Myeloid, Acute109
Precursor Cell Lymphoblastic Leukemia-Lymphoma85
Leukemia82
Primary Myelofibrosis81
Leukemia, Lymphocytic, Chronic, B-Cell73
Leukemia, Myelomonocytic, Chronic71
Lymphoma, Non-Hodgkin67
Multiple Myeloma67

Trials

Showing 51 to 75 of 217. Each trial links to its page on Pharma Observatory.

117 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.